Shingo Tojo

City:

Osaka

Country:

Japan

Published Applications:

Last publication date:

2021-06-10

Top Assignees for applications by Shingo Tojo

The entities that hold a legal rights for patent applications filed by inventor Tojo Shingo:

Sumitomo Dainippon Pharma Co., Ltd. 3 Osaka, Japan
BOSTON BIOMEDICAL, INC. 2 Cambridge, MA United States
SUMITOMO DAINIPPON PHARMA CO., LTD. 1 Osaka-shi, Osaka, Japan
Sumitomo Pharma Co., Ltd. 1 Osaka, Japan

Recent patent applications by Tojo Shingo

Shingo Tojo from Osaka, JP has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2021-06-10

US20210171440A1

Chemistry; metallurgy

1,4-disubstituted imidazole derivative

#2 | 2019-06-06

US20190169191A1

Chemistry; metallurgy

Substituted purine derivative

#3 | 2019-02-28

US20190060282A1

Human necessities

Imidazolylamide derivative

#4 | 2018-08-16

US20180230085A1

Chemistry; metallurgy

1,4-disubstituted imidazole derivative

#5 | 2017-06-15

US20170166552A1

Chemistry; metallurgy

1,4-disubstituted imidazole derivative

#6 | 2016-03-17

US20160075697A1

Chemistry; metallurgy

HETEROCYCLIC SUBSTITUTED-3-HETEROARYLIDENYL-2-INDOLINONE DERIVATIVE

#7 | 2016-02-04

US20160031888A1

Chemistry; metallurgy

3-(ARYL OR HETEROARYL) METHYLENEINDOLIN-2-ONE DERIVATIVES AS INHIBITORS OF CANCER STEM CELL PATHWAY KINASES FOR THE TREATMENT OF CANCER

#8 | 2014-09-18

US20140275076A1

Chemistry; metallurgy

Heterocyclic substituted-3-heteroarylidenyl-2-indolinone derivative

#9 | 2009-03-26

US20090082332A1

Chemistry; metallurgy

PURINE DERIVATIVES FOR THE TREATMENT OF VIRAL OR ALLERGIC DISEASES AND CANCERS

InventorID:

1430765 ⎘